Citations (4)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Chuan Tan, Yanyan Huang, Zheng Huang, Yuanjia Ning, Lizheng Huang, Xianjian Wu, Yuan Lu, Huamei Wei & Jian Pu. (2023) N6-Methyladenosine-Modified ATP8B1-AS1 Exerts Oncogenic Roles in Hepatocellular Carcinoma via Epigenetically Activating MYC. Journal of Hepatocellular Carcinoma 10, pages 1479-1495.
Read now
Read now
Articles from other publishers (3)
Xuan Liu, Xuelong Xie, Chentao Sui, Xuexue Liu, Miao Song, Qing Luo, Ping Zhan, Jia Feng & Jinbo Liu. (2024)
Unraveling the cross‐talk between
N6
‐methyladenosine modification and non‐coding
RNAs
in breast cancer: Mechanisms and clinical implications
. International Journal of Cancer 154:11, pages 1877-1889.
Crossref
Crossref
Xin Li, Wanming Li, Jie Wang, Qun Wang, Menghu Liang, Shuo Chen, Wei Ba & Jin Fang. (2024) Establishment of a novel microfluidic co-culture system for simultaneous analysis of multiple indicators of gefitinib sensitivity in colorectal cancer cells. Microchimica Acta 191:5.
Crossref
Crossref
Shaocheng Zhou, Lijuan Sheng, Lin Zhang, Jianan Zhang & Lei Wang. (2024) METTL3/IGF2BP3-regulated m6A modification of HYOU1 confers doxorubicin resistance in breast cancer. Biochimica et Biophysica Acta (BBA) - General Subjects 1868:3, pages 130542.
Crossref
Crossref